Ventum Financial set a C$10.00 target price on 5N Plus (TSE:VNP – Free Report) in a report published on Thursday,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.
Several other research analysts have also weighed in on VNP. Raymond James upped their price target on 5N Plus from C$7.50 to C$8.50 in a research report on Friday, September 6th. National Bankshares upped their target price on 5N Plus from C$8.00 to C$8.50 in a report on Tuesday, November 5th. Finally, Desjardins raised their price target on shares of 5N Plus from C$7.25 to C$8.50 and gave the stock a “buy” rating in a report on Tuesday, September 10th. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of C$8.60.
Get Our Latest Report on 5N Plus
5N Plus Price Performance
Insiders Place Their Bets
In other 5N Plus news, Director Jean-Marie Bourassa purchased 9,000 shares of the company’s stock in a transaction dated Friday, November 15th. The shares were bought at an average price of C$6.75 per share, for a total transaction of C$60,750.00. Insiders own 4.91% of the company’s stock.
About 5N Plus
5N Plus Inc produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells.
Read More
- Five stocks we like better than 5N Plus
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The 3 Best Retail Stocks to Shop for in August
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Dividends? Buy the Best Dividend Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for 5N Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 5N Plus and related companies with MarketBeat.com's FREE daily email newsletter.